CIS Pharma AG is a pioneering company in the life sciences sector, focusing on innovative solutions in oncology and ophthalmology. The company specializes in synthesizing novel molecules and developing advanced biomaterials, which are essential for creating cutting-edge medical devices aimed at enhancing treatment outcomes. Their commitment to improving the risk-benefit profile of existing therapies underscores their dedication to advancing healthcare, particularly in the areas of eye health and cancer treatment. Located in the life science cluster of Basel, Switzerland, CIS Pharma collaborates with leading scientists and industry experts to bring new therapies to market.

In addition to their work in oncology and ophthalmology, CIS Pharma is also involved in the development of smart biomaterials and connected medical devices, such as a connected eye drop dispenser. This innovative approach not only aims to improve patient compliance but also enhances the overall effectiveness of treatments. The company’s long-standing history, dating back to its founding in 1952, reflects its ongoing commitment to research and development, positioning CIS Pharma as a key player in the global pharmaceutical landscape.

Switzerland

CIS Pharma is an independent pharmaceutical research and development company that was established in 1952. It is based in the Basel Area, Switzerland and focuses on developing next-gen immuno-conjugates, ADCs, and radioligand. The company also specializes in novel contact lens coating technology.

CIS Pharma

Company Details